These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22241164)

  • 41. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P50-N100-P200 sensory gating deficits in adolescents and young adults with autism spectrum disorders.
    Chien YL; Hsieh MH; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109683. PubMed ID: 31260720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.
    Smucny J; Stevens KE; Tregellas JR
    Pharmacol Biochem Behav; 2014 Mar; 118():22-9. PubMed ID: 24418217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia.
    Bak N; Rostrup E; Larsson HB; Glenthøj BY; Oranje B
    Hum Brain Mapp; 2014 Aug; 35(8):3578-87. PubMed ID: 24375687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consistency of abnormal sensory gating in first-admission and chronic schizophrenia across quantification methods.
    Schubring D; Popov T; Miller GA; Rockstroh B
    Psychophysiology; 2018 Apr; 55(4):. PubMed ID: 28940501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings.
    de Wilde OM; Bour LJ; Dingemans PM; Koelman JH; Linszen DH
    Schizophr Bull; 2007 Nov; 33(6):1319-23. PubMed ID: 17289652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
    Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
    Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic effects of cannabis on sensory gating.
    Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N
    Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
    Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
    Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.
    Adler LE; Cawthra EM; Donovan KA; Harris JG; Nagamoto HT; Olincy A; Waldo MC
    Am J Psychiatry; 2005 Feb; 162(2):386-8. PubMed ID: 15677607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic brain functional network based on EEG microstate during sensory gating in schizophrenia.
    Chang Q; Li C; Zhang J; Wang C
    J Neural Eng; 2022 Mar; 19(2):. PubMed ID: 35130537
    [No Abstract]   [Full Text] [Related]  

  • 54. Normal P50 Gating in Children with Autism, Yet Attenuated P50 Amplitude in the Asperger Subcategory.
    Madsen GF; Bilenberg N; Jepsen JR; Glenthøj B; Cantio C; Oranje B
    Autism Res; 2015 Aug; 8(4):371-8. PubMed ID: 25599888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study.
    Schneider S; Bahmer TJ; Metzger FG; Reif A; Polak T; Pfuhlmann B; Walter G; Eberle MC; Ernst LH; Fallgatter AJ; Ehlis AC
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1911-25. PubMed ID: 23759203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Psychiatry Res; 2011 May; 187(1-2):49-54. PubMed ID: 21075453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept study.
    Tregellas JR; Smucny J; Legget KT; Stevens KE
    Schizophr Res; 2015 Dec; 169(1-3):351-354. PubMed ID: 26453015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auditory sensory processing deficits in sensory gating and mismatch negativity-like responses in the social isolation rat model of schizophrenia.
    Witten L; Oranje B; Mørk A; Steiniger-Brach B; Glenthøj BY; Bastlund JF
    Behav Brain Res; 2014 Jun; 266():85-93. PubMed ID: 24613239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
    Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.